Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia

American Journal of Cardiology

Volumn 93, Issue 6, 2004, Pages 702-704

  Asada, Junko ^b   Tsuji, Hisako ^a   Iwasaka, Toshiji ^b   Thomas, James D ^b   Lauer, Michael S ^b  

^a Health Examination Center of Moriguchi City   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE; DOBUTAMINE;

ADULT; AGE; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART STRESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK; VALVULAR HEART DISEASE;

AGED; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; DOBUTAMINE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 1542512542     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.051     Document Type: Article

References (11)

1. Williams M.J., Odabashian J., Lauer M.S., Thomas J.D., Marwick T.H. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 27:1996;132-139.
2. Cheung B.M., Kumana C.R. Natriuretic peptides - relevance in cardiovascular disease. JAMA. 280:1998;1983-1984.
3. Maeda K., Tsutamoto T., Wada A., Hisanaga T., Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 135:1998;825-832.
4. De Bruyne B., Bronzwaer J., Heyndrickx G., Paulus W. Comparative effects of ischemia and hypoxemia on left ventricular systolic and diastolic function in humans. Circulation. 88:1993;461-471.
5. Kono M., Yamauchi A., Tsuji T., Misaka A., Igano K., Ueki K., Fujishima M., Ueda A., Inoue K., Nakao K., Imura H. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku Gijutsu. 13:1993;2-7.
6. Nakamura T., Sakamoto K., Yamano T., Kikkawa M., Zen K., Hikosaka T., Kubota T., Azuma A., Nishimura T. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 39:2002;1657-1663.
7. Matsumoto A., Hirata Y., Momomura S., Suzuki E., Yokoyama I., Sata M., Ohtani Y., Serizawa T. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J. 129:1995;139-145.
8. Friedl W., Mair J., Thomas S., Pichler M., Puschendorf B. Natriuretic peptides and cyclic guanosine 3′, 5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart. 76:1996;129-136.
9. De Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 345:2001;1014-1021.
10. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., Gardetto N., Wanner E., Maisel A.S. Utility of B-natriuretic peptide in detecting diastolic dysfunction comparison with Doppler velocity recordings. Circulation. 105:2002;595-601.
11. Marumoto K., Hamada M., Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci. 88:1995;551-556.